These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9720120)

  • 1. Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS).
    Müller MJ; Rossbach W; Dannigkeit P; Müller-Siecheneder F; Szegedi A; Wetzel H
    Schizophr Res; 1998 Aug; 32(3):151-60. PubMed ID: 9720120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of standardized training for the "Positive and Negative Syndrome Scale" (PANSS)].
    Müller MJ; Rossbach W; Davids E; Wetzel H; Benkert O
    Nervenarzt; 2000 Mar; 71(3):195-204. PubMed ID: 10756528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI).
    Kølbæk P; Blicher AB; Buus CW; Feller SG; Holm T; Dines D; O'Leary KM; Sørensen RS; Opler M; Correll CU; Mors O; Bech P; Østergaard SD
    Nord J Psychiatry; 2018 Aug; 72(6):431-436. PubMed ID: 30037286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized training in the rating of the six-item Positive And Negative Syndrome Scale (PANSS-6).
    Kølbæk P; Dines D; Hansen J; Opler M; Correll CU; Mors O; Østergaard SD
    Schizophr Res; 2021 Feb; 228():438-446. PubMed ID: 33578367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of inter-rater reliability of PANSS items and subscales by a standardized rater training.
    Müller MJ; Wetzel H
    Acta Psychiatr Scand; 1998 Aug; 98(2):135-9. PubMed ID: 9718240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia.
    Lindström E; Wieselgren IM; von Knorring L
    Acta Psychiatr Scand; 1994 Mar; 89(3):192-5. PubMed ID: 8178678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing positive and negative symptoms in children and adolescents.
    Fields JH; Grochowski S; Lindenmayer JP; Kay SR; Grosz D; Hyman RB; Alexander G
    Am J Psychiatry; 1994 Feb; 151(2):249-53. PubMed ID: 8296898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrater reliability of the Japanese version of the Positive and Negative Syndrome Scale and the appraisal of its training effect.
    Igarashi Y; Hayashi N; Yamashina M; Otsuka N; Kuroki N; Anzai N; Kazamatsuri H
    Psychiatry Clin Neurosci; 1998 Oct; 52(5):467-70. PubMed ID: 10215006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia.
    Nielsen CM; Kølbæk P; Dines D; Pedersen ML; Danielsen AA; Holmgård C; Wissing S; Esbøl AM; Fuglsang NFB; Nguyen TD; Mors O; Opler M; Correll CU; Østergaard SD
    J Psychopharmacol; 2022 Nov; 36(11):1208-1217. PubMed ID: 36268705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS.
    Cruz BF; de Resende CB; Abreu MN; Rocha FL; Teixeira AL; Keefe RS; Salgado JV
    Cogn Neuropsychiatry; 2013 May; 18(3):243-51. PubMed ID: 23145794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview.
    Kølbæk P; Dines D; Holm T; Blicher AB; Sørensen RD; O'Leary KM; Feller SG; Buus CW; Nielsen CM; Opler M; Mors O; Correll CU; Østergaard SD
    J Psychopharmacol; 2021 Sep; 35(9):1081-1090. PubMed ID: 33779360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS).
    Khan A; Yavorsky WC; Liechti S; DiClemente G; Rothman B; Opler M; DeFries A; Jovic S
    J Clin Psychopharmacol; 2013 Feb; 33(1):109-17. PubMed ID: 23277234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Thai version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia: criterion validity and interrater reliability.
    Nilchaikovit T; Uneanong S; Kessawai D; Thomyangkoon P
    J Med Assoc Thai; 2000 Jun; 83(6):646-51. PubMed ID: 10932491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and reliability of the Polish version of the Positive and Negative Syndrome Scale (PANSS).
    Rzewuska M
    Int J Methods Psychiatr Res; 2002; 11(1):27-32. PubMed ID: 12459802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.
    Bell M; Milstein R; Beam-Goulet J; Lysaker P; Cicchetti D
    J Nerv Ment Dis; 1992 Nov; 180(11):723-8. PubMed ID: 1431824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audio-digital recordings to assess ratings reliability in clinical trials of schizophrenia.
    Targum SD; Pendergrass JC; Murphy C
    Schizophr Res; 2021 Jun; 232():54-60. PubMed ID: 34015556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability.
    von Knorring L; Lindström E
    Acta Psychiatr Scand; 1992 Dec; 86(6):463-8. PubMed ID: 1281960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic modelling of antipsychotic drugs in patients with schizophrenia: part II: the use of subscales of the PANSS score.
    Pilla Reddy V; Kozielska M; Suleiman AA; Johnson M; Vermeulen A; Liu J; de Greef R; Groothuis GM; Danhof M; Proost JH
    Schizophr Res; 2013 May; 146(1-3):153-61. PubMed ID: 23473811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnitude of rater differences in assessment scales for schizophrenia.
    Suzuki T; Takeuchi H; Nakajima S; Nomura K; Uchida H; Yagi G; Watanabe K; Kashima H
    J Clin Psychopharmacol; 2010 Oct; 30(5):607-11. PubMed ID: 20814326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.
    Sarró S; Dueñas RM; Ramírez N; Arranz B; Martínez R; Sánchez JM; González JM; Saló L; Miralles L; San L
    Schizophr Res; 2004 Jun; 68(2-3):349-56. PubMed ID: 15099616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.